FBCs are the only monitoring requirement with IBRANCE.1* Prior to initiating treatment with IBRANCE, patients should have their full blood count, liver function tests and urea and electrolytes testing, as well as testing as clinically required throughout treatment.1
It is recommended to monitor FBCs on Days 1 and 15 of the first cycle and on Day 1 of each cycle thereafter.1
For patients who experience a maximum of Grade 1 or 2 neutropenia in the first 6 cycles, FBCs for subsequent cycles should be monitored every 3 months, prior to the beginning of a cycle and as clinically indicated.
*Other tests as clinically required
1. IBRANCE Summary of Product Characteristics.